Literature DB >> 33263204

An Ultrahigh-Field-Tailored T1 -T2 Dual-Mode MRI Contrast Agent for High-Performance Vascular Imaging.

Jin Wang1, Yinhang Jia2, Qiyue Wang1, Zeyu Liang1,3, Guangxu Han2, Zejun Wang2, Jiyoung Lee1, Meng Zhao1,3, Fangyuan Li1, Ruiliang Bai2,4,5, Daishun Ling1,4,3.   

Abstract

The assessment of vascular anatomy and functions using magnetic resonance imaging (MRI) is critical for medical diagnosis, whereas the commonly used low-field MRI system (≤3 T) suffers from low spatial resolution. Ultrahigh field (UHF) MRI (≥7 T), with significantly improved resolution and signal-to-noise ratio, shows great potential to provide high-resolution vasculature images. However, practical applications of UHF MRI technology for vascular imaging are currently limited by the low sensitivity and accuracy of single-mode (T1 or T2 ) contrast agents. Herein, a UHF-tailored T1 -T2 dual-mode iron oxide nanoparticle-based contrast agent (UDIOC) with extremely small core size and ultracompact hydrophilic surface modification, exhibiting dually enhanced T1 -T2 contrast effect under the 7 T magnetic field, is reported. The UDIOC enables clear visualization of microvasculature as small as ≈140 µm in diameter under UHF MRI, extending the detection limit of the 7 T MR angiography. Moreover, by virtue of high-resolution UHF MRI and a simple double-checking process, UDIOC-based dual-mode dynamic contrast-enhanced MRI is successfully applied to detect tumor vascular permeability with extremely high sensitivity and accuracy, providing a novel paradigm for the precise medical diagnosis of vascular-related diseases.
© 2020 Wiley-VCH GmbH.

Entities:  

Keywords:  DCE-MRI; MRI contrast agents; dual-mode contrast agents; magnetic nanoparticles; vascular imaging

Year:  2020        PMID: 33263204     DOI: 10.1002/adma.202004917

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  5 in total

1.  One-Step Preparation of Highly Stable Copper-Zinc Ferrite Nanoparticles in Water Suitable for MRI Thermometry.

Authors:  Dorota Lachowicz; John Stroud; Janusz H Hankiewicz; River Gassen; Angelika Kmita; Joanna Stepień; Zbigniew Celinski; Marcin Sikora; Jan Zukrowski; Marta Gajewska; Marek Przybylski
Journal:  Chem Mater       Date:  2022-04-20       Impact factor: 10.508

Review 2.  Bioimaging guided pharmaceutical evaluations of nanomedicines for clinical translations.

Authors:  Ruslan G Tuguntaev; Abid Hussain; Chenxing Fu; Haoting Chen; Ying Tao; Yan Huang; Lu Liu; Xing-Jie Liang; Weisheng Guo
Journal:  J Nanobiotechnology       Date:  2022-05-19       Impact factor: 9.429

3.  High relaxivity Gd3+-based organic nanoparticles for efficient magnetic resonance angiography.

Authors:  Zhuang Liu; Menglong Zhao; Han Wang; Zi Fu; Hongbo Gao; Weijun Peng; Dalong Ni; Wei Tang; Yajia Gu
Journal:  J Nanobiotechnology       Date:  2022-03-31       Impact factor: 10.435

4.  Revisiting the factors influencing the magnetic resonance contrast of Gd2O3 nanoparticles.

Authors:  Yanyue Liu; Yingfan Dai; Haifeng Li; Dida Duosiken; Na Tang; Kang Sun; Ke Tao
Journal:  Nanoscale Adv       Date:  2021-10-25

5.  Improving the sensitivity of T 1 contrast-enhanced MRI and sensitive diagnosing tumors with ultralow doses of MnO octahedrons.

Authors:  Lijiao Yang; Lili Wang; Guoming Huang; Xuan Zhang; Lanlan Chen; Ao Li; Jinhao Gao; Zijian Zhou; Lichao Su; Huanghao Yang; Jibin Song
Journal:  Theranostics       Date:  2021-05-08       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.